Accueil・Liste d'Actions・IQVIA Holdings Inc

IQVIA Holdings Inc

Fermé

SecteurSoins de santé

236.14 -2.23

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

235.3

Max

237.73

Chiffres clés
By Trading Economics
Revenu	-17M 258M
Ventes	217M 4.4B
P/E Moyenne du Secteur	30.137 57.002
BPA	2.75
Marge bénéficiaire	5.907
Employés	94,000
EBITDA	-18M 790M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+15.54% upside

Dividendes
By Acuity
Prochains Résultats	27 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	4.2B 40B
Ouverture précédente	238.37
Clôture précédente	236.14

Sentiment de l'Actualité

By Acuity

14%

86%

28 / 340 Classement par Healthcare

IQVIA Holdings Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 19:46 UTC

IQVIA Holdings Inc. shares are lower today, reflecting broader market trends following disappointing U.S. retail sales data for July. No specific company news was identified.

13 août 2026, 22:01 UTC

IQVIA Holdings Inc. shares are lower in after-market trading, despite broader market gains and a record close for the S&P 500.

12 août 2026, 19:46 UTC

News

IQVIA Holdings reported $3.2 billion in new bookings for Q2 2026, but shares are trading lower despite strong growth metrics.

11 août 2026, 22:46 UTC

IQVIA Holdings Inc shares are trading higher in after-market hours, showing strength despite a broader market decline influenced by rising crude oil prices.

10 août 2026, 23:01 UTC

IQVIA Holdings Inc is trading higher in after-market hours, maintaining a steady upward trajectory and positioning above its 20-day moving average.

8 août 2026, 00:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours amid broader market concerns over Federal Reserve interest rate policies and a recent weak jobs report.

7 août 2026, 23:01 UTC

IQVIA Holdings Inc shares are lower in after-market hours, continuing a decline since Friday's close with no specific news identified for the drop.

6 août 2026, 20:06 UTC

IQVIA Holdings Inc shares are declining today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this movement.

5 août 2026, 20:03 UTC

Correlated Moves

News

IQVIA Holdings announced a collaboration with Medera to advance cardiac gene therapies. Positive sentiment from this partnership likely supported shares trading higher today.

4 août 2026, 23:01 UTC

News

IQVIA Holdings Inc announced a collaboration with Medera to enhance cardiac gene therapies. Shares declined during after-market trading, continuing a trend of lower closes.

3 août 2026, 20:06 UTC

IQVIA Holdings Inc. shares are lower today, breaking a trend of higher closes since Friday. No specific company news was identified to explain the move.

31 juil. 2026, 19:16 UTC

News

Shares of IQVIA Holdings lower after first-quarter results.

30 juil. 2026, 23:02 UTC

IQVIA Holdings Inc shares are higher in after-market trading, reflecting positive momentum since Thursday's close, despite no specific news driving the movement.

29 juil. 2026, 22:06 UTC

Correlated Moves

IQVIA Holdings shares declined in after-hours trading, reflecting broader market unease following the Federal Reserve's decision to maintain interest rates.

28 juil. 2026, 20:51 UTC

IQVIA Holdings Inc is trading lower in after-market hours, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

27 juil. 2026, 23:12 UTC

IQVIA Holdings Inc. shares are higher in after-market trading, tracking broader gains in European markets, including a rise in the DAX 30 Index.

23 juil. 2026, 20:03 UTC

Correlated Moves

IQVIA Holdings Inc shares are higher, supported by a rise in Thermo Fisher Scientific Inc's stock and positive sentiment in the life sciences sector.

22 juil. 2026, 16:36 UTC

IQVIA Holdings Inc shares are lower today, continuing a trend of declines. Broader market sentiment is affected by rising crude oil prices and geopolitical tensions.

21 juil. 2026, 19:06 UTC

Social Media

Shares of IQVIA Holdings Inc are lower following disappointing first-quarter results. Unusual call options activity exceeding $2 million indicates heightened investor interest.

Comparaison

Variation de prix

IQVIA Holdings Inc prévision

Objectif de Prix

By TipRanks

15.54% hausse

Prévisions sur 12 Mois

Moyen 273.43 USD 15.54%

Haut 300 USD

Bas 240 USD

Basé sur 16 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

16 ratings

Achat

Maintien

Vente

Basé sur 16 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

28 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.